Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR1A | P08908 | 2/20 | 0.72 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.72 |
| ▸ | TBXA2R | P21731 | 2/20 | 0.72 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.72 |
| ▸ | HTR2A | P28223 | 2/20 | 0.72 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.72 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.72 |
| ▸ | HTR2B | P41595 | 2/20 | 0.72 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.72 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.72 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.72 |
| ▸ | CNR1 | P21554 | 1/20 | 0.72 |
| ▸ | HTR2C | P28335 | 1/20 | 0.72 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.72 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.72 |
| ▸ | ADRB3 | P13945 | 12/20 | 0.52 |
| ▸ | ADRB2 | P07550 | 11/20 | 0.52 |
| ▸ | ADRB1 | P08588 | 11/20 | 0.52 |
| ▸ | FABP3 | P05413 | 1/20 | 0.47 |
| ▸ | FABP4 | P15090 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30680200 | 1.00 | HTR1A (0.72) | HTR1AADORA3TBXA2RSLC6A2HTR2A | |
| SCHEMBL11090316 | 0.89 | NR1I2 (0.67) | HTR1AADORA3TBXA2RSLC6A2HTR2A | |
| SCHEMBL9825342 | 0.89 | ADORA3 (0.57) | HTR1AADORA3TBXA2RSLC6A2HTR2A | |
| SCHEMBL8882786 | 0.85 | ADORA3 (0.55) | HTR1AADORA3TBXA2RSLC6A2HTR2A | |
| SCHEMBL8882790 | 0.85 | ADORA3 (0.55) | HTR1AADORA3TBXA2RSLC6A2HTR2A | |
| SCHEMBL9798370 | 0.84 | NR1I2 (0.57) | HTR1AADORA3TBXA2RSLC6A2HTR2A | |
| SCHEMBL11090539 | 0.84 | NR1I2 (0.78) | HTR1AADORA3TBXA2RSLC6A2HTR2A | |
| SCHEMBL2454428 | 0.84 | ADORA3 (0.54) | HTR1AADORA3TBXA2RSLC6A2HTR2A | |
| SCHEMBL2454425 | 0.84 | ADORA3 (0.54) | HTR1AADORA3TBXA2RSLC6A2HTR2A | |
| Croconazole SCHEMBL34369 | 0.83 | NR1I2 (1.00) | HTR1AADORA3TBXA2RSLC6A2HTR2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 698 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12391729-B2 | Fusion proteins, recombinant bacteria, and methods for using recombinant bacteria | SPOGEN BIOTECH INC. (US) | 2025-08-19 | — | — | US | claimed |
| US-20240199709-A1 | FUSION PROTEINS, RECOMBINANT BACTERIA, AND METHODS FOR USING RECOMBINANT BACTERIA | SPOGEN BIOTECH INC (US) | 2024-06-20 | — | — | US | claimed |
| US-11905315-B2 | Fusion proteins, recombinant bacteria, and methods for using recombinant bacteria | SPOGEN BIOTECH INC. (US) | 2024-02-20 | — | — | US | claimed |
| US-20210179672-A1 | FUSION PROTEINS, RECOMBINANT BACTERIA, AND METHODS FOR USING RECOMBINANT BACTERIA | GENISYS CREDIT UNION | 2021-06-17 | — | — | US | claimed |
| EP-2533633-B1 | FUNGICIDAL MIXTURES | LANXESS DISTRIB GMBH (DE) | 2017-02-01 | — | — | EP | claimed |
| WO-2016044655-A2 | FUSION PROTEINS, RECOMBINANT BACTERIA, AND METHODS FOR USING RECOMBINANT BACTERIA | SPOGEN BIOTECH INC. (US) | 2016-03-24 | — | — | WO | claimed |
| US-20130195997-A1 | FUNGICIDAL MIXTURES | LANXESS DISTRIBUTION GMBH (DE) | 2013-08-01 | — | — | US | claimed |
| EP-2533633-A2 | FUNGICIDAL MIXTURES | LANXESS Distribution GmbH (DE) | 2012-12-19 | — | — | EP | claimed |
| EP-2460408-A1 | Nematicidal compositions | deVGen N.V. (BE) | 2012-06-06 | — | — | EP | claimed |
| US-20110319435-A1 | FUNGICIDE MIXTURES | LANXESS DISTRIBUTION GMBH (DE) | 2011-12-29 | — | — | US | claimed |
| WO-2011095492-A2 | FUNGICIDAL MIXTURES | LANXESS DISTRIBUTION GMBH (DE) | 2011-08-11 | — | — | WO | claimed |
| EP-2315522-A2 | FORMATE-CONTAINING FUNGICIDE MIXTURES | LANXESS Distribution GmbH (DE) | 2011-05-04 | — | — | EP | claimed |
| EP-2153720-A1 | Fungicide mixtures comprising formate | LANXESS Distribution GmbH (DE) | 2010-02-17 | — | — | EP | claimed |
| WO-2010015635-A2 | FUNGICIDE MIXTURES | LANXESS DISTRIBUTION GMBH (DE) | 2010-02-11 | — | — | WO | claimed |
| US-4483866-A | FUNGICIDE | SHIONOGI & CO., LTD. (JP) | 1984-11-20 | — | — | US | claimed |
| US-12630484-B2 | Methods for promoting plant health using free enzymes and microorganisms that overexpress enzymes | SPOGEN BIOTECH INC. (US) | 2026-05-19 | — | — | US | disclosed |
| US-12599141-B2 | Rod-shaped plant viral nanoparticles or virus-like particles for agricultural applications | CASE WESTERN RESERVE UNIVERSITY (US) | 2026-04-14 | — | — | US | disclosed |
| CN-1013443-B | PROCESS FOR PREPARING IMIDAZOLE DERIVATIVES | SHIONOGI & CO (JP) | 1991-08-07 | — | — | CN | disclosed |
| US-4629795-A | FUNGICIDES | SHIONOGI & CO., LTD. (JP) | 1986-12-16 | — | — | US | disclosed |
| EP-0162359-A2 | A process for preparing imidazole derivatives | SHIONOGI & CO., LTD. (JP) | 1985-11-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12630484-B2 | Methods for promoting plant health using free enzymes and microorganisms that overexpress enzymes | ADA, RNGTT, GNPDA1 | HTR1A 2601/4885ADORA3 1485/4885TBXA2R 4250/4885 |
| US-12599141-B2 | Rod-shaped plant viral nanoparticles or virus-like particles for agricultural applications | PRNP, PCNP, VIM | HTR1A 1246/4885ADORA3 4377/4885TBXA2R 3685/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.